Supporting Awareness for Autoimmune Diseases in May

Autoimmune diseases like rheumatoid arthritis and lupus are a major cause of chronic illness and disability in the United States and elsewhere.

They occur when the body’s immune system, which normally fights off bacteria and viruses, attacks healthy cells by mistake, causing inflammation and other problems. Research is underway to better understand why this happens and what treatments might be beneficial for specific groups of patients, including those with severe forms of disease whose symptoms persist despite standard medical therapies.

As a company working to manage complex challenges with innovative solutions, we’re making strides to better address the needs of underserved patients who need individualized treatment plans. We’re listening and engaging with patient communities to identify gaps in care and solutions for improving awareness of autoimmune diseases and how to best manage these chronic conditions. We’re committed to better understanding every patient’s unique challenges to help improve outcomes and maintain their health in the best ways possible.

“Every day we work to help patients, their loved ones and caregivers have options that can improve their lives. Our collaborations with the patient community help promote awareness, action and informed decision-making that can enhance care,” noted Tunde Otulana, M.D., Senior Vice President and Chief Medical Officer at Mallinckrodt.

Living with an autoimmune disease can be a daily struggle and the ability to perform simple tasks like walking up steps, folding laundry, buttoning a shirt or driving may become challenging. Some patients require special accommodations that can make them feel stigmatized and misunderstood. Coping with an autoimmune disease can be overwhelming, affect a person’s emotional health and well-being, and impact families and loved ones. Patients frequently require support from caregivers along with physical or occupational therapy and other treatments.

Symptoms can appear and resolve or gradually worsen and may vary for every patient. Individuals often struggle with frustrating and confusing symptoms for years before getting an accurate diagnosis, which delays treatment and getting better. It’s critical for patients to seek treatment initially and when symptom flares occur. Treatment to reduce inflammation and manage symptoms may be different for each patient and it may help prevent permanent damage to the body. Frequently, managing a chronic illness requires support from family and friends, along with self-care, including proper nutrition, engaging in activities or hobbies, exercise and meditation.

As part of our commitment to patients, we proudly support national awareness months in May for rheumatoid arthritis, myositis and lupus. Working together, we can reduce the burden of illness for all patients, family members and caregivers who are affected by autoimmune disease.

More information can be found at:

National Arthritis Awareness Month

Lupus Awareness Month

Myositis Awareness Month

Above are links to third-party websites (“Third-Party Content”). The Third-Party Content is meant for informational purposes only, is not endorsed by or under the control of Mallinckrodt ARD LLC, and is not meant to replace a physician’s medical advice. Mallinckrodt ARD LLC has no responsibility or liability for and makes no representations or warranties whatsoever about any third-party content. All trademarks, service marks, and logos appearing on these websites are the property of their respective owners. Any rights not expressly granted herein are reserved.

Mallinckrodt, the “M” brand mark and the Mallinckrodt Pharmaceuticals logo are trademarks of a Mallinckrodt company. Other brands are trademarks of a Mallinckrodt company or their respective owners. ©2019 Mallinckrodt. US-1900675 5/19